Molecule Details
| InChIKey | KMGBJIFKTYDXGK-IARZGTGTSA-N |
|---|---|
| Compound Name | (5S)-N-[(1S,2R)-1-benzyl-2-hydroxy-3-[(2-thiophenylmethyl)-[(2,4,5-trifluorophenyl)sulfonyl]amino]propyl]-2-oxo-3-phenyloxazolidine-5-carboxamide |
| Canonical SMILES | O=C(N[C@@H](Cc1ccccc1)[C@H](O)CN(Cc1cccs1)S(=O)(=O)c1cc(F)c(F)cc1F)[C@@H]1CN(c2ccccc2)C(=O)O1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.77 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
Target Activities (2)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P03369 | gag-pol | Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2) | Pathogen | PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098 | 6.8 | Ki | BindingDB |
| Q72874 | pol | Human immunodeficiency virus type 1 | Pathogen | PF00077 | 6.8 | Ki | ChEMBL |